Patents by Inventor Goran Bertilsson

Goran Bertilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM USING AGENTS THAT DECREASE THE ACTIVITY OF THE MELANOCORTIN 4 RECEPTOR
    Publication number: 20100129319
    Abstract: Novel methods are provided for modulating CNS cell neogenesis in the CNS cells in vitro or in vivo, involving the use of agents that decrease the activity of the melanocortin 4 receptor (MC4R). When the methods of the invention are applied to a subject such as a human, it may be used for reducing a symptom of a CNS disorder.
    Type: Application
    Filed: December 14, 2007
    Publication date: May 27, 2010
    Inventors: Per Lindquist, Goran Bertilsson, Alex Mercer, Cesare Patrone, Lilian Wikstrom, Olof Zachrisson
  • Compounds and methods for increasing neurogenesis
    Publication number: 20090232775
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis modulating agents. Novel methods for treating neurological disorders using neurogenesis modulating agents are disclosed.
    Type: Application
    Filed: August 11, 2008
    Publication date: September 17, 2009
    Inventors: Goran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellstrom, Johan Haggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Screening methods
    Patent number: 7238498
    Abstract: A mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) is useful for the inhibition of angiogenesis and/or tumor progression. Screening methods exist to identify compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
    Type: Grant
    Filed: December 30, 2005
    Date of Patent: July 3, 2007
    Assignee: AngioGenetics Sweden AB
    Inventors: Anders Berkenstam, Göran Bertilsson, Lorenz Poellinger
  • Screening Methods
    Patent number: 7214770
    Abstract: The present invention relates a mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) which polypeptide is useful for the inhibition of angiogenesis and/or tumor progression. The invention also relates to screening methods for compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: May 8, 2007
    Assignee: Angiogenetics Sweden AB
    Inventors: Anders Berkenstam, Göran Bertilsson, Lorenz Poellinger
  • SCREENING METHODS
    Publication number: 20060115849
    Abstract: A mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) is useful for the inhibition of angiogenesis and/or tumor progression. Screening methods exist to identify compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
    Type: Application
    Filed: December 30, 2005
    Publication date: June 1, 2006
    Applicant: ANGIOGENETICS SWEDEN AB
    Inventors: Anders Berkenstam, Goran Bertilsson, Lorenz Poellinger
  • Compounds and methods for increasing neurogenesis
    Publication number: 20060079448
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis modulating agents. Novel methods for treating neurological disorders using neurogenesis modulating agents are disclosed.
    Type: Application
    Filed: November 28, 2005
    Publication date: April 13, 2006
    Inventors: Goran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellstrom, Johan Haggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Compounds and methods for increasing neurogenesis
    Patent number: 6969702
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis increasing agents. Novel methods for treating neurological disorders using neurogenesis increasing agents are disclosed.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: November 29, 2005
    Assignee: NeuroNova AB
    Inventors: Göran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellström, Johan Häggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Rönnholm, Lilian Wikström, Olof Zachrisson
  • Compounds and methods for increasing neurogenesis
    Publication number: 20050209142
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis modulating agents. Novel methods for treating neurological disorders using neurogenesis modulating agents are disclosed.
    Type: Application
    Filed: November 19, 2004
    Publication date: September 22, 2005
    Inventors: Goran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellstrom, Johan Haggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Compounds and methods for increasing neurogenesis
    Publication number: 20050009847
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with intracellular cAMP elevating agents and intracellular Ca2+ elevating agents. Novel agents for promoting neurogenesis are disclosed. These agents include novel agents for increasing intracellular cAMP.
    Type: Application
    Filed: November 20, 2003
    Publication date: January 13, 2005
    Inventors: Goran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellstrom, Johan Haggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Compounds and methods for increasing neurogenesis
    Publication number: 20050009742
    Abstract: The invention is directed to methods of promoting neurogenesis by contacting neuronal tissue with neurogenesis modulating agents. Novel methods for treating neurological disorders using neurogenesis modulating agents are disclosed.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 13, 2005
    Inventors: Goran Bertilsson, Rikard Erlandsson, Jonas Frisen, Anders Haegerstrand, Jessica Heidrich, Nina Hellstrom, Johan Haggblad, Katarina Jansson, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Karl Nyberg, Amina Ossoinak, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Therapeutic use of selective LXR modulators
    Publication number: 20050003998
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via LXR signaling. These methods are useful for reducing at least one symptom of the disorder.
    Type: Application
    Filed: August 15, 2003
    Publication date: January 6, 2005
    Inventors: Goran Bertilsson, Jessica Heidrich, Johan Haggblad, Harriet Ronnholm, Olof Zachrisson
  • Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells
    Publication number: 20030165485
    Abstract: The invention relates generally to methods of influencing central nervous system cells to produce progeny useful in the treatment of CNS disorders. More specifically, the invention includes methods of exposing a patient suffering from such a disorder to a reagent that modulates the proliferation, migration, differentiation and survival of central nervous system cells via Reelin, Gas6 or Protein S signaling. These methods are useful for reducing at least one symptom of the disorder.
    Type: Application
    Filed: November 8, 2002
    Publication date: September 4, 2003
    Inventors: Goran Bertilsson, Anna Falk, Jonas Frisen, Jessica Heidrich, Kristina Hellstrom, Jarkko Kortesmaa, Per Lindquist, Hanna Lundh, Jacqueline McGuire, Alex Mercer, Cesare Patrone, Harriet Ronnholm, Lilian Wikstrom, Olof Zachrisson
  • Screening methods
    Publication number: 20020165140
    Abstract: The present invention relates a mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) which polypeptide is useful for the inhibition of angiogenesis and/or tumor progression. The invention also relates to screening methods for compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
    Type: Application
    Filed: June 29, 2001
    Publication date: November 7, 2002
    Inventors: Anders Berkenstam, Goran Bertilsson, Lorenz Poellinger
  • Promoter sequences
    Publication number: 20020150915
    Abstract: The present invention relates to an isolated human Cytochrome P-450 3A7 (CYP3A7) promoter region. The invention also relates to screening methods for agents modulating the expression of CYP3A7, such agents being potentially useful in modulating metabolism of endogenous and/or exogenous compounds, drug interaction, toxicity and/or bioavailability of drugs.
    Type: Application
    Filed: September 21, 2001
    Publication date: October 17, 2002
    Inventors: Anders Berkenstam, Goran Bertilsson, Patrik Blomquist